TXAC’s IPO Confirms the New Terms Standard of Zero Warrants

spac ipos

TXAC’s IPO Confirms the New Terms Standard of Zero Warrants

At least for small, tightly focused SPACs. Similar to Panacea Acquisition Corp.’s IPO last Wednesday (PANA.U), Therapeutics Acquisition Corp. (TXAC), came roaring right out of the gate to open at $11.25.  However, it’s currently trading in the $12.00 range after going as high as $13.50.  And Therapeutics does not have any warrants included as part
Read More
To access this post, you must purchase a Monthly or Yearly SPACInsider Subscription, or log in if you're a member.

Leave a Reply